BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17585879)

  • 1. The NMR solution structure of recombinant RGD-hirudin.
    Song X; Mo W; Liu X; Zhu L; Yan X; Song H; Dai L
    Biochem Biophys Res Commun; 2007 Aug; 360(1):103-8. PubMed ID: 17585879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H NMR assignment and secondary structure of recombinant RGD-hirudin.
    Liu X; Yan X; Mo W; Song H; Dai L
    Magn Reson Chem; 2005 Nov; 43(11):956-61. PubMed ID: 16103990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance solution structure of hirudin(1-51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain.
    Szyperski T; Güntert P; Stone SR; Wüthrich K
    J Mol Biol; 1992 Dec; 228(4):1193-205. PubMed ID: 1335515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR solution structure of a novel hirudin variant HM2, N-terminal 1-47 and N64-->V + G mutant.
    Nicastro G; Baumer L; Bolis G; Tatò M
    Biopolymers; 1997 Jun; 41(7):731-49. PubMed ID: 9128439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure study of recombinant RGD-hirudin by vibrational and circular dichroism spectroscopy.
    Liu X; Mo W; Dai L; Yan X; Song H
    Protein Pept Lett; 2006; 13(1):47-51. PubMed ID: 16454669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refined structure of the hirudin-thrombin complex.
    Rydel TJ; Tulinsky A; Bode W; Huber R
    J Mol Biol; 1991 Sep; 221(2):583-601. PubMed ID: 1920434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational stability of a thrombin-binding peptide derived from the hirudin C-terminus.
    Ni F; Ripoll DR; Purisima EO
    Biochemistry; 1992 Mar; 31(9):2545-54. PubMed ID: 1547237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of protein-protein contacts on the conformation of thrombin-bound hirudin studied by comparison with the nuclear magnetic resonance solution structure of hirudin(1-51).
    Szyperski T; Güntert P; Stone SR; Tulinsky A; Bode W; Huber R; Wüthrich K
    J Mol Biol; 1992 Dec; 228(4):1206-11. PubMed ID: 1474586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of recombinant hirudin and the Lys-47----Glu mutant: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study.
    Folkers PJ; Clore GM; Driscoll PC; Dodt J; Köhler S; Gronenborn AM
    Biochemistry; 1989 Mar; 28(6):2601-17. PubMed ID: 2567183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of RGD-hirudin binding to thrombin: Tyr3 and five C-terminal residues are crucial for inhibiting thrombin activity.
    Huang Y; Zhang Y; Zhao B; Xu Q; Zhou X; Song H; Yu M; Mo W
    BMC Struct Biol; 2014 Dec; 14():26. PubMed ID: 25526801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
    De Simone G; Lombardi A; Galdiero S; Nastri F; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V
    Protein Sci; 1998 Feb; 7(2):243-53. PubMed ID: 9521099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fermentation, purification and identification of recombinant RGD-Hirudin].
    Mo W; Zhang YL; Wang LS; Yang XY; Song HY
    Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):126-9. PubMed ID: 16108503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-bound conformation of a cyclic anticoagulant peptide using transferred nuclear Overhauser effect (NOE), distance geometry, and NOE simulations.
    Ning Q; Ripoll DR; Szewczuk Z; Konishi Y; Ni F
    Biopolymers; 1994 Sep; 34(9):1125-37. PubMed ID: 7948726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refinement of the thrombin-bound structure of a hirudin peptide by a restrained electrostatically driven Monte Carlo method.
    Ripoll DR; Ni F
    Biopolymers; 1992 Apr; 32(4):359-65. PubMed ID: 1623131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition.
    Mo W; Zhang YL; Chen HS; Wang LS; Song HY
    J Thromb Thrombolysis; 2009 Aug; 28(2):230-7. PubMed ID: 18998199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient hydrogen bonds identified on the surface of the NMR solution structure of Hirudin.
    Szyperski T; Antuch W; Schick M; Betz A; Stone SR; Wüthrich K
    Biochemistry; 1994 Aug; 33(31):9303-10. PubMed ID: 8049231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
    Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y
    Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments.
    Chang JY
    J Biol Chem; 1990 Dec; 265(36):22159-66. PubMed ID: 2266119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the structure of hirudin from Hirudinaria manillensis by limited proteolysis. Isolation, characterization and thrombin-inhibitory properties of N-terminal fragments.
    Vindigni A; De Filippis V; Zanotti G; Visco C; Orsini G; Fontana A
    Eur J Biochem; 1994 Dec; 226(2):323-33. PubMed ID: 8001550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of a complex of recombinant hirudin and human alpha-thrombin.
    Rydel TJ; Ravichandran KG; Tulinsky A; Bode W; Huber R; Roitsch C; Fenton JW
    Science; 1990 Jul; 249(4966):277-80. PubMed ID: 2374926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.